IRD · Opus Genetics, Inc. · Proposed Sales
Market Cap
$430.12M
Shares
83.20M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-03 | Gagnon Robert E. | Officer | 28,000 | 2026-09-03 | Jefferies LLC |
| 2026-07-23 | SCHACHLE JOSEPH K | Officer | 4,644 | 2026-07-23 | Raymond James & Associates |
| 2026-07-23 | Magrath George | Officer | 9,475 | 2026-07-23 | Jefferies LLC |
| 2026-07-23 | YERXA BENJAMIN R | Officer | 7,429 | 2026-07-23 | Raymond James & Associates |
| 2026-07-23 | Gagnon Robert E. | Officer | 7,783 | 2026-07-23 | Jefferies LLC |
| 2026-04-23 | YERXA BENJAMIN R | Officer | 7,470 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | Jayagopal Ashwath | Officer | 7,542 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | SCHACHLE JOSEPH K | Officer | 4,697 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | Gagnon Robert E. | Officer | 7,842 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | Magrath George | Officer | 9,511 | 2026-04-23 | Raymond James & Associates |
| 2026-03-16 | Magrath George | Officer | 24,438 | 2026-03-16 | Raymond James & Associates |
Showing 1–11 of 11 filings